That doesn't mean they don't seem to be contemplating it. Various breakthrough therapy designations happen to be granted for psilocybin while in the treatment of resistant depression—that's, depression that does not respond to at least two differing types of antidepressants—and also a broader approval could be over the horizon. The https://remingtonrdpai.qodsblog.com/29804172/facts-about-microdosing-mushrooms-for-pain-revealed